SCHEMBL5772744

SCHEMBL5772744

CCOC(=O)c1[nH]c(-c2cccc(Cl)c2)cc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.50
ALDH1A1 P00352 4/20 0.50
HPGD P15428 2/20 0.50
CYP1A2 P05177 1/20 0.50
XBP1 P17861 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTGES O14684 1/20 0.48
JAK2 O60674 1/20 0.47
JAK3 P52333 1/20 0.47
TRPM8 Q7Z2W7 1/20 0.47
CSF1R P07333 1/20 0.45
MAPT P10636 2/20 0.45
HTT P42858 1/20 0.45
ALOX15 P16050 3/20 0.44
TRPV1 Q8NER1 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773315 0.88 ALDH1A1 (0.50) ALOX5ALDH1A1HPGDCYP1A2XBP1
SCHEMBL5771002 0.86 GCGR (0.55) ALOX5ALDH1A1HPGDCYP1A2XBP1
SCHEMBL5775657 0.85 ALDH1A1 (0.52) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL5771719 0.84 SLC6A2 (0.48) ALOX5ALDH1A1HPGDCYP1A2XBP1
SCHEMBL5773864 0.82 MAPT (0.50) ALDH1A1HPGDMAPTHTTKDM4E
SCHEMBL2748256 0.79 LMNA (0.54) ALDH1A1HPGDCYP1A2CYP2C19MAPT
SCHEMBL5776076 0.79 GRM6 (0.50) ALOX5ALDH1A1HPGDCYP1A2XBP1
SCHEMBL21264058 0.78 MAPT (0.54) ALDH1A1HPGDCYP1A2CYP2C19MAPT
SCHEMBL5774019 0.78 MAPT (0.54) ALDH1A1HPGDCYP1A2CYP2C19TRPM8
SCHEMBL2748270 0.77 HPGD (0.56) ALDH1A1HPGDJAK2JAK3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed